Log in

Cellectar Biosciences SEC Filings & 10K Form (NASDAQ:CLRB)

$2.17
-0.12 (-5.24 %)
(As of 02/23/2020 04:00 PM ET)
Today's Range
$2.15
Now: $2.17
$2.46
50-Day Range
$2.17
MA: $2.63
$3.17
52-Week Range
$1.04
Now: $2.17
$3.75
Volume288,894 shs
Average Volume274,505 shs
Market Capitalization$20.40 million
P/E RatioN/A
Dividend YieldN/A
Beta1.35

SEC Filings

Cellectar Biosciences (NASDAQ:CLRB) SEC Filings

DateFilerForm TypeView
02/19/2020
7:15 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
4:08 PM
Anson Funds Management LP (Filed by)
Cellectar Biosciences (Subject)
Form SC 13G/A
02/11/2020
6:03 AM
Cellectar Biosciences (Subject)
UBS Group AG (Filed by)
Form SC 13G/A
02/11/2020
5:15 AM
Cellectar Biosciences (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SC 13G/A
01/09/2020
3:03 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
3:02 PM
Cellectar Biosciences (Issuer)
Grachev Igor D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
3:01 PM
Cellectar Biosciences (Issuer)
Grachev Igor D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2020
3:01 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
3:07 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
3:03 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2019
3:01 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
7:33 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
7:16 AM
Cellectar Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2019
3:09 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
3:07 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
3:01 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2019
3:02 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
3:25 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
3:02 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2019
3:24 PM
Cellectar Biosciences (Issuer)
Elefant Dov (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
3:23 PM
Cellectar Biosciences (Issuer)
Elefant Dov (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2019
3:42 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
3:08 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2019
3:16 PM
Cellectar Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/20/2019
3:03 PM
Cellectar Biosciences (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
08/15/2019
7:30 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2019
3:15 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
7:30 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
7:16 AM
Cellectar Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/09/2019
3:05 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
3:32 PM
Cellectar Biosciences (Issuer)
HILL STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:32 PM
Cellectar Biosciences (Issuer)
Loren Stefan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:32 PM
Cellectar Biosciences (Issuer)
DRISCOLL FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:31 PM
Cellectar Biosciences (Issuer)
Swirsky Douglas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:31 PM
Cellectar Biosciences (Issuer)
NEIS JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:04 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
11:15 PM
Cellectar Biosciences (Filer)
Form EFFECT
05/31/2019
4:24 PM
Cellectar Biosciences (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/31/2019
4:17 PM
Cellectar Biosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
05/28/2019
3:31 PM
Boxer Capital, LLC (Filed by)
Cellectar Biosciences (Subject)
Form SC 13G
05/28/2019
3:21 PM
Cellectar Biosciences (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
05/28/2019
2:58 PM
Anson Funds Management LP (Filed by)
Cellectar Biosciences (Subject)
Form SC 13G
05/24/2019
5:08 AM
Cellectar Biosciences (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SC 13G
05/21/2019
3:20 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
4:30 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2019
4:24 PM
Cellectar Biosciences (Filer)
Form 424B5
05/16/2019
8:01 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
3:21 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2019
3:01 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
3:31 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
3:12 PM
Cellectar Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2019
3:04 PM
Cellectar Biosciences (Filer)
Form DEF 14A
04/19/2019
7:00 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2019
3:05 PM
Cellectar Biosciences (Filer)
Form PRE 14A
03/11/2019
3:02 PM
Bernhardt Charles Thomas III (Reporting)
Cellectar Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/08/2019
3:03 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2019
3:20 PM
Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
8:01 AM
Cellectar Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2019
7:41 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2019
3:03 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2019
3:01 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2019
1:42 PM
Cellectar Biosciences (Subject)
UBS Group AG (Filed by)
Form SC 13G
01/29/2019
8:15 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2019
3:18 PM
Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
3:17 PM
Cellectar Biosciences (Issuer)
POSNER BRIAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
3:17 PM
CARUSO JAMES V (Reporting)
Cellectar Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
3:05 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
8:20 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2018
3:01 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2018
3:01 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2018
5:23 PM
CARUSO JAMES V (Reporting)
Cellectar Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
5:19 PM
Cellectar Biosciences (Issuer)
HILL STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
3:02 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
8:01 AM
Cellectar Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2018
7:45 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
5:04 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2018
6:51 PM
Cellectar Biosciences (Issuer)
NEIS JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2018
6:50 PM
Cellectar Biosciences (Issuer)
Loren Stefan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2018
6:50 PM
Cellectar Biosciences (Issuer)
HILL STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2018
6:49 PM
Cellectar Biosciences (Issuer)
DRISCOLL FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2018
6:49 PM
Cellectar Biosciences (Issuer)
Swirsky Douglas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2018
6:49 PM
Cellectar Biosciences (Issuer)
POSNER BRIAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2018
6:48 PM
Cellectar Biosciences (Issuer)
Friend John E. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2018
6:47 PM
Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2018
6:47 PM
CARUSO JAMES V (Reporting)
Cellectar Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
8:22 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2018
3:01 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2018
3:05 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2018
3:01 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2018
8:21 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2018
3:00 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2018
5:14 PM
Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
3:01 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2018
7:31 AM
Cellectar Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2018
7:15 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2018
3:53 PM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2018
3:07 PM
Cellectar Biosciences (Filer)
Form 424B4
07/27/2018
7:45 AM
Cellectar Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2018
11:15 PM
Cellectar Biosciences (Filer)
Form EFFECT
07/26/2018
6:17 PM
Cellectar Biosciences (Filer)
Form S-1MEF
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel